Detalhe da pesquisa
1.
2'-O-Methylation of the second transcribed nucleotide within the mRNA 5' cap impacts the protein production level in a cell-specific manner and contributes to RNA immune evasion.
Nucleic Acids Res
; 50(16): 9051-9071, 2022 09 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36018811
2.
DYRK1a mediates BAFF-induced noncanonical NF-κB activation to promote autoimmunity and B-cell leukemogenesis.
Blood
; 138(23): 2360-2371, 2021 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34255829
3.
Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells.
Blood
; 137(5): 624-636, 2021 02 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32902645
4.
TP53 in Acute Myeloid Leukemia: Molecular Aspects and Patterns of Mutation.
Int J Mol Sci
; 22(19)2021 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34639121
5.
Exploring tryptamine conjugates as pronucleotides of phosphate-modified 7-methylguanine nucleotides targeting cap-dependent translation.
Bioorg Med Chem
; 28(13): 115523, 2020 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32362385
6.
The rarity of ALDH(+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients.
Int J Cancer
; 137(3): 525-36, 2015 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25545165
7.
Age-specific induction of mutant p53 drives clonal hematopoiesis and acute myeloid leukemia in adult mice.
Cell Rep Med
; 5(5): 101558, 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38733986
8.
Transcriptional and phenotypic heterogeneity underpinning venetoclax resistance in AML.
bioRxiv
; 2024 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38352538
9.
Mitochondrial regulation of GPX4 inhibition-mediated ferroptosis in acute myeloid leukemia.
Leukemia
; 38(4): 729-740, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38148395
10.
Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis in vitro.
Biochem Pharmacol
; 220: 115981, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38081370
11.
Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma.
Nat Commun
; 15(1): 1203, 2024 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38331987
12.
Comprehensive characterization of IFNγ signaling in acute myeloid leukemia reveals prognostic and therapeutic strategies.
Nat Commun
; 15(1): 1821, 2024 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38418901
13.
The cross-talk between macrophages and tumor cells as a target for cancer treatment.
Front Oncol
; 13: 1259034, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38033495
14.
Preclinical investigations of the efficacy of the glutaminase inhibitor CB-839 alone and in combinations in chronic lymphocytic leukemia.
Front Oncol
; 13: 1161254, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37228498
15.
Targeting Unc51-like Autophagy Activating Kinase 1 (ULK1) Overcomes Adaptive Drug Resistance in Acute Myelogenous Leukemia.
Mol Cancer Res
; 21(6): 548-563, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36787422
16.
PD-1 blockade in combination with dasatinib potentiates induction of anti-acute lymphocytic leukemia immunity.
J Immunother Cancer
; 11(10)2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37793852
17.
Single-Cell Profiling of CD8+ T Cells in Acute Myeloid Leukemia Reveals a Continuous Spectrum of Differentiation and Clonal Hyperexpansion.
Cancer Immunol Res
; : OF1-OF18, 2023 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37285177
18.
Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis.
Res Sq
; 2023 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37162954
19.
Single-Cell Profiling of CD8+ T Cells in Acute Myeloid Leukemia Reveals a Continuous Spectrum of Differentiation and Clonal Hyperexpansion.
Cancer Immunol Res
; 2023 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37163233
20.
Targeting DNA2 Overcomes Metabolic Reprogramming in Multiple Myeloma.
bioRxiv
; 2023 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36865225